EU MDR Classification Rules (Annex VIII): Complete Guide to All 22 Rules with 2026 Updates
Deep walkthrough of all 22 EU MDR classification rules in Annex VIII — non-invasive, invasive, active, and special rules — with MDD-to-MDR changes, software and nanomaterial up-classification, MDCG 2021-24 guidance, and practical strategies for correct device classification.
Getting Classification Right Is the Most Critical First Step in EU Market Access
Classification determines everything about your regulatory pathway under the EU Medical Device Regulation (MDR 2017/745). It dictates the conformity assessment route, the depth of clinical evidence required, whether a Notified Body must be involved, the scope of post-market surveillance obligations, and ultimately how long and how much it costs to get your device to market. Misclassify, and you face submission rejection, market withdrawal, or enforcement action by competent authorities.
The MDR defines 22 classification rules in Annex VIII, organized into four groups: non-invasive devices (Rules 1-4), invasive devices (Rules 5-8), active devices (Rules 9-13), and special rules (Rules 14-22). The regulation also added four entirely new rules compared to the old Medical Device Directive (MDD) — Rules 19 through 22 — covering nanomaterials, inhalation devices, substance-based devices, and Annex XVI aesthetic products.
This guide provides a rule-by-rule walkthrough with practical classification examples, explains what changed from MDD to MDR, and incorporates the latest MDCG 2021-24 guidance on classification of medical devices.
The Four Risk Classes Under EU MDR
The MDR maintains the same four-tier risk classification as the old MDD, but the rules that assign devices to those classes have been significantly revised:
| Class | Risk Level | Examples | Notified Body Required | Conformity Assessment |
|---|---|---|---|---|
| Class I | Low | Bandages, wheelchairs, manual surgical instruments | No (self-declaration) | Article 52(7) — self-certification |
| Class Is | Low (sterile) | Sterile surgical drapes, sterile dressings | Yes | Annex IX, or Annex XI Part A |
| Class Im | Low (measuring) | Non-invasive thermometers, measuring cups | Yes | Annex IX, or Annex XI Part A |
| Class Ir | Low (reusable surgical) | Reusable surgical scalpels, retractors | Yes | Annex IX, or Annex XI Part A |
| Class IIa | Moderate | Ultrasound devices, orthodontic wires, hearing aids | Yes | Annex IX, Annex X + XI Part A, or Annex XI Part B |
| Class IIb | Medium-high | Ventilators, CT scanners, blood bags, hip implants | Yes | Annex IX, or Annex X + XI Part A |
| Class III | High | Pacemakers, heart valves, breast implants, stents | Yes | Annex IX (full QMS + tech doc review) + scrutiny |
Class I devices can be self-certified by the manufacturer, but all other classes require Notified Body involvement. The three Class I sub-classes (Is, Im, Ir) were introduced by the MDR — under the MDD, some of these devices did not require Notified Body assessment.
Classification Principles: How the Rules Work
Before diving into individual rules, understand the classification methodology defined in Annex VIII Chapter I and the implementing rules in Chapter II:
Duration of use is the first axis of classification:
- Transient: less than 60 minutes of continuous use
- Short-term: between 60 minutes and 30 days
- Long-term: more than 30 days
Invasiveness determines which rule group applies:
- Non-invasive: devices that do not penetrate the body surface
- Invasive: devices that penetrate the body through a body orifice or surgically
- Surgically invasive: devices that penetrate the body through a surgical opening
- Implantable: devices intended to be totally introduced into the body or to replace an epithelial surface
Active devices are any device that depends on a source of energy other than that generated by the human body or gravity, and that acts by changing the density of or converting that energy.
The Implementing Rules (Annex VIII, Chapter II)
These six rules govern how to apply the classification rules:
- Apply all rules: Classification is determined by the intended purpose of the device and the rules must be applied in the order set out.
- Highest class prevails: If a device is covered by multiple rules, the strictest rule (highest class) applies.
- Accessories classified separately: An accessory to a medical device is classified in its own right, not based on the device it accompanies.
- Combination products: A device combined with a medicinal product is classified under Rule 14 (but if the medicinal substance action is principal, it falls under medicines regulation).
- Software classification: Software that drives or influences a device is classified as the device itself. Standalone software is classified per Rule 11.
- Multiple intended purposes: If a device has multiple intended purposes, the strictest applicable rule determines classification.
Rules 1–4: Non-Invasive Devices
Rule 1 — Default Class I
All non-invasive devices are classified as Class I unless one of the other rules applies. This is the catch-all default. Examples include hospital beds, non-sterile bandages, and manual massage devices.
Rule 2 — Channelling and Storing Body Fluids
Devices intended for channelling or storing blood, body liquids, cells, tissues, liquids, or gases for eventual infusion or administration into the body:
- Class IIa if they may be connected to a Class IIa, IIb, or III active device, or if intended for channelling/storing blood or body liquids
- Class IIb for blood bags specifically
Examples: IV tubing sets (IIa), blood bags (IIb), enteral feeding sets (IIa).
Rule 3 — Modifying Biological or Chemical Composition
Devices intended for modifying the biological or chemical composition of human tissues, cells, blood, or other body liquids:
- Class IIb in general
- Class IIa if the treatment consists of filtration, centrifugation, or exchange of gas, heat
- Class III for devices used in vitro with human embryos before implantation or administration
Rule 4 — Disinfecting and Cleaning Devices
Devices intended for disinfecting or cleaning medical devices:
- Class IIa for general disinfection/sterilization of medical devices
- Class IIb for disinfecting solutions or washer-disinfectors used as the endpoint of processing invasive devices
- Class IIb for contact lens disinfection devices
Rules 5–8: Invasive Devices
Rule 5 — Body Orifice Invasive Devices
Devices (not surgically invasive) intended for use in body orifices:
- Class I if transient use
- Class IIa if short-term use, unless used in the oral cavity, ear canal, or nasal cavity (where they remain Class I) and not potentially hazardous
- Class IIb if long-term use
Examples: Nasal speculums (I), urinary catheters (IIa), long-term nasal stents (IIb).
Rule 6 — Surgically Invasive Devices, Transient Use
Surgically invasive devices for transient use:
- Class IIa in general
- Class IIb if intended for use in direct contact with the heart, central circulatory system, or central nervous system; or for controlled exposure to ionizing radiation; or for biological effect
- Class III if used in direct contact with the heart or central nervous system
Rule 7 — Surgically Invasive Devices, Short-Term Use
Surgically invasive devices for short-term use:
- Class IIa in general
- Class IIb if intended for use in direct contact with the heart, central circulatory system, or central nervous system; or for controlled exposure to ionizing radiation; or for biological effect or absorption
- Class III if specifically intended for direct contact with the heart, central circulatory system, or central nervous system
Rule 8 — Implantable and Long-Term Surgically Invasive Devices
This is one of the most critical rules. All implantable and long-term surgically invasive devices are Class IIb unless they:
- Are placed in the teeth → Class IIa
- Are used in direct contact with the heart, central circulatory system, or central nervous system → Class III
- Have a biological effect or are wholly or mainly absorbed → Class III
- Intended to undergo chemical change in the body (except if placed in teeth) → Class III
- Are breast implants or surgical meshes → Class III (MDR-specific up-classification)
- Are total or partial joint replacements → Class IIb (unless used in direct contact with CNS/heart)
- Are spinal disc replacement implants → Class IIb or Class III depending on invasiveness
The MDR significantly expanded Class III designations under Rule 8 compared to the MDD, notably adding breast implants, surgical meshes, and certain substance-based implants.
Rules 9–13: Active Devices
Rule 9 — Active Therapeutic Devices
Active devices intended to administer or exchange energy:
- Class IIa if they administer energy in a non-potentially hazardous way (e.g., ultrasound physiotherapy)
- Class IIb if they administer energy in a potentially hazardous way (e.g., defibrillators, electrosurgical units)
- Class III if they control, monitor, or directly influence the performance of active implantable devices
Rule 10 — Active Diagnostic Devices
Active devices intended for diagnosis or monitoring:
- Class IIa if they supply energy for imaging or monitoring physiological processes (e.g., ECG monitors, ultrasound imaging)
- Class IIb if they monitor vital physiological parameters where variations could result in immediate danger (e.g., patient monitors in ICU), or emit ionizing radiation (e.g., X-ray, CT)
Rule 11 — Software (MDR's Most Impactful New Rule)
This rule has had the most dramatic impact on classification since the MDR took effect:
- Class I for all software not covered by other classifications
- Class IIa for software intended to provide information used for diagnosis or therapeutic decisions
- Class IIb for software where decisions could cause serious deterioration of health or a surgical intervention
- Class III for software where decisions could cause death or irreversible deterioration of health
Additionally, software intended to monitor physiological processes is Class IIa, or Class IIb if monitoring vital parameters where variations could result in immediate danger.
What changed from MDD: Under the old directive, most standalone software was Class I with minimal regulatory oversight. The MDR up-classified virtually all diagnostic and decision-support software, making it one of the most debated regulatory changes. MDCG 2019-11 provides specific guidance on software classification, and the 2025 revision of MDCG 2021-24 further clarified the boundary for clinical decision support software.
Rule 12 — Active Devices Administering Substances
Active devices intended to administer or remove medicinal products, body liquids, or other substances:
- Class IIa in general
- Class IIb if done in a potentially hazardous manner, considering the nature of substances, body part concerned, and mode of application
Examples: Infusion pumps (IIa or IIb depending on risk), anesthesia machines (IIb).
Rule 13 — Other Active Devices
All other active devices are Class I. This includes devices like examination lights, powered surgical tables, and hospital bed controls.
Rules 14–22: Special Rules
Rule 14 — Devices Incorporating Medicinal Substances
All devices incorporating or consisting of a human blood derivative, or incorporating a medicinal substance that has an ancillary action to that of the device, are Class III.
Examples: Heparin-coated catheters (III), drug-eluting stents (III), collagen sponges containing thrombin (III).
Rule 15 — Contraceptive and STI Prevention Devices
All devices used for contraception or prevention of sexually transmitted infections are Class IIb, unless they are implantable or long-term invasive, in which case they are Class III.
Rule 16 — Disinfecting and Cleaning Specific Devices
- Contact lens disinfecting devices → Class IIb
- Medical device disinfection/sterilization → Class IIa (or Class IIb if for invasive device end-point processing)
Rule 17 — X-Ray Diagnostic Imaging Devices
Devices specifically intended for recording diagnostic images generated by X-ray radiation are Class IIa.
Rule 18 — Devices Using Human or Animal Tissues
All devices manufactured utilizing tissues or cells of human or animal origin (non-viable or rendered non-viable) are Class III, unless they use animal tissues that only contact intact skin.
Rule 19 — Nanomaterial Devices (New in MDR)
Devices incorporating or consisting of nanomaterial:
- Class III if high or medium potential for internal exposure
- Class IIb if low potential for internal exposure
- Class IIa if negligible potential for internal exposure
Examples include wound dressings with silver nanoparticles, nano-coated catheters, and dental nanocomposites. The classification depends on whether the nanomaterial can become systemically available and at what concentration.
Rule 20 — Invasive Inhalation Devices (New in MDR)
All invasive devices with respect to body orifices (other than surgically invasive) intended to administer medicinal products by inhalation are Class IIb, unless they have a critical impact on the functioning of the administered medicinal product or the device is intended to treat life-threatening conditions, in which case they are Class III.
Examples: Metered-dose inhalers (IIb), nebulizers for critical medications (III).
Rule 21 — Substance-Based Devices (New in MDR)
Devices composed of substances or combinations of substances intended to be introduced into the body through a body orifice or applied to skin and that are absorbed by or locally dispersed in the body:
- Class III if they are absorbed or locally dispersed in the body (excluding those applied to skin only)
- Class IIa if applied to the skin
- Class IIb if introduced via body orifice
This rule was specifically introduced because the MDD did not adequately address the risk profile of substance-based devices like dermal fillers and absorbable hemostats.
Rule 22 — Annex XVI Products Without Medical Purpose (New in MDR)
Devices listed in Annex XVI that do not have a medical purpose (aesthetic and cosmetic devices) are classified using specific criteria. These include:
- Contact lenses and other items introduced into or onto the eye
- Products intended to be injected or otherwise introduced into the body for filling, augmentation, or replacement
- Equipment for tattooing or micropigmentation
- Products intended for skin improvement or modification
- Equipment for brain stimulation applying electrical currents or electromagnetic fields
Most of these products are classified at Class IIa or higher, with invasive substance-based aesthetic products reaching Class III.
MDD vs. MDR: Key Classification Changes
| Aspect | MDD (93/42/EEC) | MDR (2017/745) |
|---|---|---|
| Total rules | 18 | 22 (4 new: Rules 19-22) |
| Software | Generally Class I | Rule 11 with explicit up-classification |
| Nanomaterials | No specific rule | Rule 19 (new) |
| Substance-based devices | Could be Class I | Rule 21 — up-classified |
| Aesthetic/cosmetic | Not regulated as devices | Rule 22 + Annex XVI |
| Reusable surgical instruments | Class I (self-certified) | Class Ir (Notified Body required) |
| Breast implants | Class IIb or III | Rule 8 → Class III |
| Surgical mesh | Class IIb | Rule 8 → Class III |
| Active implantable devices | Separate AIMDD regulation | MDR Rule 8 → Class III |
| Inhalation admin devices | Not specifically addressed | Rule 20 (new) |
Classification Methodology: Step-by-Step Process
Follow this systematic approach to classify any medical device under Annex VIII:
Step 1 — Define intended purpose. The manufacturer's stated intended purpose is the starting point. This includes what the device does, how it is used, who uses it, and where on the body it acts. Classification is based on intended purpose, not design features alone.
Step 2 — Determine key characteristics. Assess the device for: (a) duration of use (transient, short-term, long-term), (b) degree of invasiveness (non-invasive, body orifice invasive, surgically invasive, implantable), (c) whether it is an active device, and (d) any special characteristics (nanomaterials, medicinal substances, animal tissue).
Step 3 — Apply all relevant rules. Go through all 22 rules. Do not stop at the first applicable rule — the implementing rules require that you identify every rule that could apply.
Step 4 — Apply the strictest rule. If multiple rules apply, the rule resulting in the highest classification prevails. Document your rationale for each rule considered.
Step 5 — Document and justify. Prepare a classification rationale document that references the specific rule numbers, sub-provisions, and your reasoning. This document will be reviewed by your Notified Body.
Step 6 — Verify with guidance. Cross-reference against MDCG 2021-24 (Rev. 1, January 2025), which provides interpretation guidance for classification, including specific cases for software, combination products, and custom-made devices.
Practical Classification Examples
| Device | Key Characteristics | Applicable Rule(s) | Classification |
|---|---|---|---|
| Standard adhesive bandage | Non-invasive, transient, intact skin only | Rule 1 | Class I |
| Sterile surgical drape | Non-invasive, sterile | Rule 1 + Class Is provision | Class Is |
| Digital thermometer (non-invasive) | Non-invasive, measuring function | Rule 1 + Class Im provision | Class Im |
| Reusable surgical scalpel | Surgically invasive, transient | Rule 6 + Class Ir provision | Class Ir |
| Urinary catheter | Body orifice invasive, short-term | Rule 5 | Class IIa |
| IV infusion set | Channelling body fluids, connected to active device | Rule 2 | Class IIa |
| Blood bag | Channelling/storing blood | Rule 2 | Class IIb |
| Ultrasound imaging system | Active diagnostic, non-invasive | Rule 10 | Class IIa |
| CT scanner | Active diagnostic, emits ionizing radiation | Rule 10 | Class IIb |
| Ventilator | Active therapeutic, potentially hazardous energy | Rule 9 | Class IIb |
| Drug-eluting stent | Implantable, incorporates medicinal substance | Rules 8 + 14 | Class III |
| AI-based cardiac monitoring software | Software, monitors vital parameters | Rule 11 | Class IIb or III |
| Breast implant | Implantable | Rule 8 (specific provision) | Class III |
| Dermal filler (absorbable) | Substance-based, absorbed by body | Rule 21 | Class III |
| Silver nanoparticle wound dressing | Incorporates nanomaterial | Rule 19 | Class IIa-III (depends on exposure) |
| Pacemaker | Active implantable | Rule 8 | Class III |
2026 Updates: What Has Changed This Year
EUDAMED Mandatory Registration (May 28, 2026)
As of May 28, 2026, the first four EUDAMED modules (Actor registration, Device registration, Certificates, and Market Surveillance) become mandatory for all new devices placed on the EU market. This directly impacts classification because your device class and applicable rule must be accurately entered into the EUDAMED system. Incorrect classification in EUDAMED will be flagged by Competent Authorities during market surveillance.
MDCG 2021-24 Revision 1 (January 2025)
The revised guidance added significant clarifications:
- Custom-made devices (CMDs): Must be classified in their own right, even though they are exempt from some conformity assessment requirements
- In-house manufactured devices: Devices manufactured and used within healthcare institutions must be classified, though they follow a separate regulatory pathway under Article 5(5)
- Single integral combination products: The device part must be classified separately from the medicinal product part
- Software classification boundaries: Further clarification on when software is an accessory versus a standalone device
Proposed MDR Simplification Package (December 2025)
The European Commission's December 2025 proposal includes potential changes to classification rules that could:
- Simplify reclassification procedures for devices already on the market
- Introduce a faster mechanism for updating classification rules in response to new technologies
- Adjust the software classification framework to better align with international practices (IMDRF guidance)
These changes are under legislative review and are expected to progress through 2026-2027.
Harmonised Standards Update (EU 2026/193)
The European Commission published Implementing Decision (EU) 2026/193, updating the list of harmonised standards under the MDR. While this does not change classification rules directly, it affects the conformity assessment evidence required for each class — manufacturers should review their GSPR compliance against the updated standards list.
Comparison: EU MDR vs. FDA Classification
| Aspect | EU MDR (Annex VIII) | FDA (21 CFR 862-892) |
|---|---|---|
| System | Rule-based (22 rules) | Predicate-based (risk classification + 510(k)) |
| Classes | I, IIa, IIb, III | I, II, III |
| Class III definition | Highest risk (implants, life-supporting) | Highest risk (life-supporting, life-sustaining) |
| Software | Explicit rules (Rule 11) | Case-by-case, guidance documents |
| Nanomaterials | Specific rule (Rule 19) | No specific rule |
| Notified Body / FDA | Notified Body for Class > I | FDA clearance for most Class II and all Class III |
| Burden of proof | Manufacturer classifies, NB verifies | FDA assigns classification code |
| Aesthetic devices | Regulated (Rule 22 + Annex XVI) | Not generally regulated as devices |
The EU's rule-based system provides more predictability than the FDA's predicate-based approach, but it also requires manufacturers to develop classification expertise rather than simply searching for a predicate device.
Common Classification Mistakes and How to Avoid Them
Mistake 1: Assuming MDD classification transfers directly to MDR. Many devices have been up-classified. Always re-classify from scratch using Annex VIII.
Mistake 2: Not considering all applicable rules. The implementing rules require applying every potentially relevant rule. Stopping at the first match leads to under-classification.
Mistake 3: Classifying based on design rather than intended purpose. The same physical device could be classified differently depending on its stated intended purpose. A software algorithm used for triage versus treatment monitoring will fall under different classification sub-rules.
Mistake 4: Ignoring the special rules (19-22). These new MDR rules catch devices that were previously unclassified or classified at lower levels. Substance-based devices and nanomaterial-containing products are particularly affected.
Mistake 5: Not documenting the classification rationale. Your Notified Body will challenge your classification if you cannot provide a clear, rule-by-rule justification. Prepare a formal classification rationale document for every device.
FAQ
How many classification rules are there under EU MDR?
There are 22 classification rules in Annex VIII of the MDR, compared to 18 under the old MDD. The four new rules (19-22) cover nanomaterial devices, inhalation administration devices, substance-based devices, and products without a medical purpose listed in Annex XVI.
What happens if I apply multiple rules and they give different classes?
Under the implementing rules in Annex VIII Chapter II, you must apply all relevant rules and classify the device according to the strictest (highest) applicable class. You must document each rule considered and your rationale for the final classification.
Can I challenge or request reclassification of my device?
Classification is the manufacturer's responsibility based on the device's intended purpose. If your Notified Body disagrees with your classification, they will request justification. You can adjust your intended purpose to change the applicable rules, but you cannot simply choose a lower class without a valid rationale.
How do I classify software under EU MDR?
Software is classified primarily under Rule 11. Software that provides information for diagnosis or treatment decisions is at minimum Class IIa, rising to Class IIb or III depending on the potential severity of harm from incorrect decisions. Software that merely stores or transmits data without influencing clinical decisions may be Class I. MDCG 2019-11 provides detailed guidance on software classification.
When did the new MDR classification rules take effect?
The MDR became fully applicable on May 26, 2021. However, transitional arrangements under Regulation (EU) 2023/607 allow some legacy devices certified under the MDD to remain on the market until 2027-2028, depending on their class. All new devices must be classified under MDR rules from the start.
Do accessories have the same classification as the device they work with?
No. Under MDR implementing rules, accessories are classified in their own right using the same 22 rules. An accessory to a Class III device may itself be Class I or Class IIa depending on its own characteristics.
What is MDCG 2021-24 and why does it matter for classification?
MDCG 2021-24 is the Medical Device Coordination Group's guidance document on classification of medical devices. It provides practical interpretation of the 22 rules, including specific examples and borderline cases. The January 2025 revision (Rev. 1) added guidance on custom-made devices, in-house manufactured devices, and combination products. While not legally binding, it represents the consensus view of EU Competent Authorities and is followed by all Notified Bodies.
How does EUDAMED affect classification from May 2026?
From May 28, 2026, all new devices must be registered in EUDAMED with their correct classification and applicable rule number. This makes classification accuracy a matter of public record and subject to scrutiny by Competent Authorities across all Member States. Incorrect classification in EUDAMED could trigger market surveillance action.
Are Annex XVI aesthetic products really medical devices?
Yes, under the MDR, certain products without a medical purpose listed in Annex XVI are treated as medical devices for regulatory purposes. This includes contact lenses for cosmetic purposes, dermal fillers, tattoo equipment, and certain body modification devices. They must be classified (typically under Rule 22) and meet all applicable MDR requirements, including CE marking.